Plasma Cystatin C Level is a Prognostic Marker of Morbidity and Mortality in Hospitalized Decompensated Cirrhotic Patients-Reference-Cited by-同舟云学术

Plasma Cystatin C Level is a Prognostic Marker of Morbidity and Mortality in Hospitalized Decompensated Cirrhotic Patients

Published:2021 Issue:3.4 Volume:68 Page:302-308
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Aumpan Natsuda¹,Limprukkasem Tanabute¹,Pornthisarn Bubpha¹,Vilaichone Ratha-korn²,Chonprasertsuk Soonthorn¹,Bhanthumkomol Patommatat¹,Tantiyavarong Pichaya³,Siramolpiwat Sith²

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand

2. Department of Medicine, Chulabhorn International College of Medicine (CICM), Thammasat University, Pathumthani, Thailand

3. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/68/3.4/68_302/_pdf

Reference27 articles.

1. 1. Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, Parikh CR, Consortium T-A : Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 57(2) : 753-62, 2013

2. 2. Fagundes C, Barreto R, Guevara M, Garcia E, Sola E, Rodriguez E, Graupera I, Ariza X, Pereira G, Alfaro I, Cardenas A, Fernandez J, Poch E, Gines P : A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol 59(3) : 474-81, 2013

3. 3. Garcia-Tsao G, Parikh CR, Viola A : Acute kidney injury in cirrhosis. Hepatology 48(6) : 2064-77, 2008

4. 4. Davenport A : Difficulties in assessing renal function in patients with cirrhosis : potential impact on patient treatment. Intensive Care Med 37(6) : 930-2, 2011

5. 5. Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM : Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci 63(3) : 665-75, 2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Cystatin C Level with All-cause Mortality in Patients with Liver Cirrhosis: A Meta-analysis;Current Medicinal Chemistry;2024-08

2. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis;Gut;2023-10-26

3. Evaluation of Serum Kidney Injury Markers FABP1, NGAL, Cystatin C and the Inflammatory Cytokine IL-18 in the Detection of Acute-on-Chronic Liver Failure (ACLF) Associated Acute Kidney Injury (AKI);2022-10-21